ppi-1019
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2003 (NCT00100282)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Beta amyloid A4 proteinINHIBITOR
APP inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ppi-1019
- ppi-1019
- ppi-1019
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00100334 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2004 | Praecis Pharmaceuticals |
| NCT00100282 | Phase 1 | May 1, 2003 | Praecis Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Praecis Pharmaceuticals | For profit | 2 | 2 | 2 | 2003 |
1 organizations
Page 1 / 1